Found: 5
Select item for more details and to access through your institution.
Liver safety of two nucleoside analogs plus efavirenz, nevirapine or a ritonavir-boosted protease inhibitor in HIV/HCV-coinfected drug-naïve patients.
- Published in:
- Journal of the International AIDS Society, 2010, v. 13, p. P91, doi. 10.1186/1758-2652-13-S4-P91
- By:
- Publication type:
- Article
Increased Regulatory T Cell Counts in HIV-Infected Nonresponders to Hepatitis B Virus Vaccine.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Low concordance and resistance mutation emergence in the HIV protease gene among circulating and cell-associated viruses at viral replication episodes during darunavir/ritonavir monotherapy.
- Published in:
- HIV Medicine, 2015, v. 16, n. 1, p. 57, doi. 10.1111/hiv.12170
- By:
- Publication type:
- Article
Stepped-dose versus full-dose efavirenz for HIV infection and neuropsychiatric adverse events: a randomized trial.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Efficacy, safety and pharmacokinetic of once-daily boosted saquinavir (1500/100 mg) together with 2 nucleos(t)ide reverse transcriptase inhibitors in real life: a multicentre prospective study.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article